Free eBook: Learn In Vitro Release Testing Best Practices

This eBook will help you assess how In Vitro Release Testing techniques can be applied during the product development process for semisolid dosage form products.

This eBook is based on articles from Diteba's Blog and excerpts from the whitepaper "An Alternative Approach to Bioequivalence Studies for Semi-Solid Dosage Form Products".  You will read insights from Diteba's Chief Scientific Officer and Executive Vice President of Science, Dr. Theo Kapanadze, D.Sc., Ph.D.

Dr. Kapanadze has extensive knowledge and experience in this area of study.  He has supervised multiple In Vitro Release Rate Studies which resulted in more than 18 separate FDA submissions using SUPAC protocols. These successful studies included complicated method design, development and validation and comparison studies.

Dr. Theo Kapanadze (VP of Science) leads Diteba's scientific team. Dr. Kapanadze has been involved in many successful FDA submissions using IVRT techniques.  Dr. Kapanadze brings this wealth of expertise in this field to Diteba.  We offer such services in a compliant, cost effective manner and with the available capacity to assist immediately.